References
- Cardoso F, Loibl S, Pagani O, European Society of Breast Cancer S, et al. The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer 2012;48:3355–77
- Loren AW, Mangu PB, Beck LN, American Society of Clinical O, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:2500–10
- El Hachem H, Atallah D, Grynberg M. Fertility preservation in breast cancer patients. Future Oncol 2014;10:1767–77
- Krishna I, Lindsay M. Breast cancer in pregnancy. Obstet Gynecol Clin North Am 2013;40:559–71
- Waks AG, Partridge AH. Fertility preservation in patients with breast cancer: necessity, methods, and safety. J Natl Compr Canc Netw 2016;14:355–63
- Goeckenjan M, Rosner S, Toth B, et al. Successful controlled ovarian stimulation despite elevated hCG levels after first-trimester abortion in the context of fertility preservation. Gynecol Endocrinol 2013;29:960–2
- Bosch E, Vidal C, Labarta E, et al. Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists–a randomized study. Hum Reprod 2008;23:2346–51
- Smitz J, Andersen AN, Devroey P, Arce JC. Group M. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod 2007;22:676–87
- Lossl K, Andersen CY, Loft A, et al. Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial. Hum Reprod 2008;23:1820–9
- Duijkers IJ, Hollanders HM, Willemsen WN, et al. Patterns of serum FSH, LH and hCG after i.m. or i.v. administration of hMG during pituitary suppression. Int J Fertil Menopausal Stud 1995;40:86–91
- Fauser BC, de Jong D, Olivennes F, et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 2002;87:709–15